10mg lyophilized
Melanotan-1
Melanogenesis & Dermal · 10mg / lyophilized
10mg lyophilized
- >= 99% (HPLC)
- RUO
- Out of Stock
MC1R agonism; eumelanin biosynthesis pathway
$0 USD
$0 due todayThis therapy is currently unavailable. Call the clinic at 361-355-8202 and we can tell you when it is back.
Melanotan-1 (afamelanotide) is a linear synthetic analogue of alpha-MSH with high affinity for melanocortin receptors, particularly MC1R. Research has studied its potent photoprotective effect via stimulation of eumelanin production before UV exposure.
Product Information
- Product Name
- Melanotan-1
- Product Code
- BBT-US-30-699788
- Primary Pathway
- MC1R agonism; eumelanin biosynthesis pathway
- Appearance
- White to off-white lyophilized powder
- Purity
- >= 99% (HPLC) (HPLC)
- Storage
- -20 degrees C, lyophilized, protected from light
- Shelf Life
- 24 months from manufacture date
- Manufacturer
- BlueBioTech(R) Research Facility
- Manufacturer Origin
- USA - Made in the USA
- Use Classification
- Research Use Only (RUO) - Not intended for Human or Veterinary Use
Specifications
- Sequence
- M1
- Molecular Weight
- See current COA
- Purity
- >= 99% (HPLC) (HPLC)
- Form
- Lyophilized
- Net Weight
- 10mg
- Storage
- -20 degrees C, lyophilized, protected from light
Source catalog notes primary pathway: MC1R agonism; eumelanin biosynthesis pathway.
Research References
- 2026BlueBioTech catalog profile for Melanotan-1
- 2026Source product code BBT-US-30-699788; purity >= 99% (HPLC)
Storage guidance from the source catalog: -20 degrees C, lyophilized, protected from light
Storage & Handling
-
01
Storage
-20 degrees C, lyophilized, protected from light
-
02
Shelf life
24 months from manufacture date
-
03
Classification
Research Use Only (RUO) - Not intended for Human or Veterinary Use
-
04
COA
Request the current certificate of analysis before use.
Reviewed before payment
A licensed physician reviews every request before dispensing. If approved, you complete secure payment, identity verification, and shipping from the link in your email.